CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Active, not recruiting	Phase 1	2026-04-13		NCT05168423

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Kite Pharma (a Gilead Company)	2
University of Pennsylvania	502

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Pennsylvania	Philadelphia	United States	507

Clinical trials